Title

Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE).

Document Type

Journal Article

Publication Date

2-9-2020

Journal

BMJ Open

Volume

10

Issue

2

Inclusive Pages

e034629

DOI

10.1136/bmjopen-2019-034629

Peer Reviewed

1

Open Access

1

Find in your library

Share

COinS